These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Analgesic effect of actinonin, a new potent inhibitor of multiple enkephalin degrading enzymes. Hachisu M; Hiranuma T; Murata S; Aoyagi T; Umezawa H Life Sci; 1987 Jul; 41(2):235-40. PubMed ID: 3298909 [TBL] [Abstract][Full Text] [Related]
4. Relationship between enkephalinase inhibition of thiorphan in vivo and its analgesic activity. Hachisu M; Takahashi H; Hiranuma T; Shibazaki Y; Murata S J Pharmacobiodyn; 1985 Sep; 8(9):701-10. PubMed ID: 3910797 [TBL] [Abstract][Full Text] [Related]
5. Composite effects of actinonin when inhibiting enkephalin-degrading enzymes. Hachisu M; Hiranuma T; Shibazaki Y; Uotani K; Murata S; Aoyagi T; Umezawa H Eur J Pharmacol; 1987 May; 137(1):59-65. PubMed ID: 2886348 [TBL] [Abstract][Full Text] [Related]
6. New bidentates as full inhibitors of enkephalin-degrading enzymes: synthesis and analgesic properties. Fournié-Zaluski MC; Coulaud A; Bouboutou R; Chaillet P; Devin J; Waksman G; Costentin J; Roques BP J Med Chem; 1985 Sep; 28(9):1158-69. PubMed ID: 3897541 [TBL] [Abstract][Full Text] [Related]
7. Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo. Mendelsohn LG; Johnson BG; Scott WL; Frederickson RC J Pharmacol Exp Ther; 1985 Aug; 234(2):386-90. PubMed ID: 3894620 [TBL] [Abstract][Full Text] [Related]
8. Indirect-acting strategy of opioid action instead of direct receptor activation: dual-acting enkephalinase inhibitors (DENKIs). Raffa RB; Pergolizzi JV; Taylor R; Ossipov MH; J Clin Pharm Ther; 2018 Aug; 43(4):443-449. PubMed ID: 29722031 [TBL] [Abstract][Full Text] [Related]
9. Analgesic effect of novel organogermanium compound, GE-132. Hachisu M; Takahashi H; Koeda T; Sekizawa Y J Pharmacobiodyn; 1983 Nov; 6(11):814-20. PubMed ID: 6366183 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of enkephalinase B inhibitors, and their activity on isolated enkephalin-degrading enzymes. Van Amsterdam JG; Van Buuren KJ; Blad MW; Soudijn W Eur J Pharmacol; 1987 Mar; 135(3):411-8. PubMed ID: 3556201 [TBL] [Abstract][Full Text] [Related]
11. [Enkephalinase inhibitors and molecular study of the differences between active sites of enkephalinase and angiotensin-converting enzyme]. Roques BP J Pharmacol; 1985; 16 Suppl 1():5-31. PubMed ID: 2993752 [TBL] [Abstract][Full Text] [Related]
12. Organophosphorus anticholinesterases do not mediate analgesia through inhibition of enkephalin degradation. Marchner H; Haraldsson S; Lundberg S Life Sci; 1986 Apr; 38(14):1317-21. PubMed ID: 3515093 [TBL] [Abstract][Full Text] [Related]
13. New carboxyalkyl inhibitors of brain enkephalinase: synthesis, biological activity, and analgesic properties. Fournié-Zaluski MC; Chaillet P; Soroca-Lucas E; Marçais-Collado H; Costentin J; Roques BP J Med Chem; 1983 Jan; 26(1):60-5. PubMed ID: 6298420 [TBL] [Abstract][Full Text] [Related]
14. Kelatorphan: a full inhibitor of enkephalin degrading enzymes. Biochemical and pharmacological properties, regional distribution of enkephalinase in rat brain by use of a tritiated derivative. Waksman G; Bouboutou R; Chaillet P; Devin J; Coulaud A; Hamel E; Besselievre R; Costentin J; Fournie-Zaluski MC; Roques BP Neuropeptides; 1985 Feb; 5(4-6):529-32. PubMed ID: 3839056 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of enkephalin degrading enzymes by metal chelating reagents. Altstein M; Blumberg S; Vogel Z Adv Biochem Psychopharmacol; 1982; 33():261-70. PubMed ID: 6751033 [TBL] [Abstract][Full Text] [Related]
16. [The enkephalinase mechanisms of the resistance and tolerance to the analgesic effect of morphine in rats. Differences in the effects of naloxone in morphine-sensitive, morphine-resistant and morphine-tolerant rats]. Kaliuzhnyĭ LV; Kozlov AIu; Litvinova SV Biull Eksp Biol Med; 1993 Jul; 116(7):6-9. PubMed ID: 8400186 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor. Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939 [TBL] [Abstract][Full Text] [Related]
18. Decreased enkephalinase activity following postnatal treatment with phenobarbital. Mousa S; Tjioe S; Couri D Neuropharmacology; 1985 Jan; 24(1):9-11. PubMed ID: 3885070 [TBL] [Abstract][Full Text] [Related]